(Q44673179)

English

Short posterior ciliary artery, central retinal artery, and choroidal hemodynamics in brimonidine-treated primary open-angle glaucoma patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Short posterior ciliary artery, central retinal artery, and choroidal hemodynamics in brimonidine-treated primary open-angle glaucoma patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

open-angle glaucoma

1 reference

based on heuristic

inferred from title

author name string

Karl-Georg Schmidt

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Volker Klingmüller

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Scott M Gouveia

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Neville N Osborne

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Lutz E Pillunat

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

American Journal of Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

136

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1038-1048

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Ocular perfusion pressures in different types of glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Blood-cell velocity in the nailfold capillaries of patients with normal-tension and high-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Influence of nifedipine on the visual fields of patients with optic-nerve-head diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Influence of physical exercise and nifedipine on ocular pulse amplitude

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Reduced ocular pulse amplitude in low tension glaucoma is independent of vasospasm.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Neuroprotection in relation to retinal ischemia and relevance to glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

The role of age and cardiovascular disease in glaucomatous optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

The potential of neuroprotection in glaucoma treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Blockade of voltage-sensitive Na(+) channels by the 5-HT(1A) receptor agonist 8-OH-DPAT: possible significance for neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Mechanisms of optic nerve damage in primary open angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Vitreous concentration of topically applied brimonidine tartrate 0.2%.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Clinical success and quality of life with brimonidine 0.2% or timolol 0.5% used twice daily in glaucoma or ocular t hypertension: a randomized clinical trial. Brimonidine Outcomes Study Group I

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Characterization of alpha1-adrenoceptor subtypes mediating vasoconstriction in human umbilical vein

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Alpha-vascular responses after short-term and long-term inhibition of nitric oxide synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Effect of brimonidine tartrate on ocular hemodynamic measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Effect of brimonidine on optic nerve blood flow in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

The effect of Ca2(+) -antagonist on visual field in low-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Calcium channel blockers in the management of low-tension and open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Color Doppler imaging of the eye: normal ranges, reproducibility, and observer variation.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Color Doppler imaging of the eye and orbit. Technique and normal vascular anatomy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

A clinical procedure for the measurements of the ocular pulse-pressure relationship and the ophthalmic arterial pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Color Doppler ultrasound imaging of the eye and orbit

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

The ocular blood flow tonograph: a new instrument for the measurement of intraocular pressure in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Topical carbonic anhydrase inhibition increases ocular pulse amplitude in high tension primary open angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Collateral blood supply through the ophthalmic artery: a steal phenomenon analyzed by color Doppler imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Effect of betaxolol, timolol and nimodipine on human and pig retinal arterioles.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Localization of alpha-2 adrenergic receptors in the human eye

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Adrenergic responses in isolated bovine retinal resistance arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Studies of the ocular pulse in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900631-7

7 January 2021

Identifiers

10.1016/S0002-9394(03)00631-7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44673179&oldid=2031303724"